Trials / Recruiting
RecruitingNCT06430047
Efficacy and Safety of EsoDuo®
The Role of an EsoDuo® to Control Reflux Symptoms Related to the Acid; a Multicenter, Open-labeled, Phase 4 Study [RACER Study]
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 180 (estimated)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
Clinical Trial to Evaluate the Effects of EsoDuo® in Controlling Reflux Symptoms Related to the Acid
Detailed description
The Role of an EsoDuo® to Control Reflux Symptoms Related to the Acid; a Multicenter, Open-labeled, Phase 4 Study \[RACER Study\]
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | EsoDuo® Tablet | QD, PO |
Timeline
- Start date
- 2022-11-25
- Primary completion
- 2025-01-01
- Completion
- 2025-05-01
- First posted
- 2024-05-28
- Last updated
- 2024-05-28
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06430047. Inclusion in this directory is not an endorsement.